0000030146-16-000032.txt : 20161117 0000030146-16-000032.hdr.sgml : 20161117 20161117132947 ACCESSION NUMBER: 0000030146-16-000032 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161117 DATE AS OF CHANGE: 20161117 EFFECTIVENESS DATE: 20161117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DREYFUS FUND INC CENTRAL INDEX KEY: 0000030146 IRS NUMBER: 136021175 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-00523 FILM NUMBER: 162004552 BUSINESS ADDRESS: STREET 1: THE DREYFUS CORPORATION STREET 2: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 2129226832 MAIL ADDRESS: STREET 1: C/O DREYFUS CORP STREET 2: 200 PARK AVENUE, 8TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10166 FORMER COMPANY: FORMER CONFORMED NAME: NESBETT FUND INC DATE OF NAME CHANGE: 19680607 0000030146 S000000068 DREYFUS FUND INC C000000105 DREYFUS FUND INC DREVX N-Q 1 lp1026.htm FORM N-Q lp1026.htm - Generated by SEC Publisher for SEC Filing

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT
INVESTMENT COMPANY

Investment Company Act file number

811-00523

 

 

 

The Dreyfus Fund Incorporated

 

 

(Exact name of Registrant as specified in charter)

 

 

 

 

 

 

c/o The Dreyfus Corporation

200 Park Avenue

New York, New York  10166

 

 

(Address of principal executive offices)        (Zip code)

 

 

 

 

 

Bennett A. MacDougall, Esq.

200 Park Avenue

New York, New York  10166

 

 

(Name and address of agent for service)

 

 

Registrant's telephone number, including area code: 

(212) 922-6400

 

 

Date of fiscal year end:

 

  12/31

 

Date of reporting period:

  09/30/16

 

             

 


 

FORM N-Q

Item 1.                         Schedule of Investments.

 


 

STATEMENT OF INVESTMENTS
The Dreyfus Fund Incorporated
September 30, 2016 (Unaudited)

Common Stocks - 96.9%  Shares   Value ($) 
Banks - 4.0%       
PNC Financial Services Group  250,141   22,535,203 
U.S. Bancorp  513,777   22,035,895 
      44,571,098 
Capital Goods - 6.9%       
Fortive  218,303   11,111,623 
Honeywell International  198,363   23,127,142 
Raytheon  162,500   22,121,125 
United Technologies  206,102   20,939,963 
      77,299,853 
Diversified Financials - 7.2%       
BlackRock  75,771   27,463,957 
Intercontinental Exchange  112,350   30,262,596 
Synchrony Financial  819,882   22,956,696 
      80,683,249 
Energy - 8.6%       
EOG Resources  339,110   32,795,328 
Occidental Petroleum  432,800   31,559,776 
Schlumberger  415,767   32,695,917 
      97,051,021 
Food & Staples Retailing - 1.8%       
Costco Wholesale  137,222   20,927,727 
Food, Beverage & Tobacco - 5.2%       
Coca-Cola  642,793   27,203,000 
Kellogg  176,743   13,692,280 
Molson Coors Brewing, Cl. B  158,828   17,439,314 
      58,334,594 
Health Care Equipment & Services - 10.3%       
Abbott Laboratories  529,340   22,385,789 
Boston Scientific  1,115,147 a  26,540,499 
Cardinal Health  177,733   13,809,854 
Danaher  235,977   18,498,237 
DENTSPLY SIRONA  210,683   12,520,891 
UnitedHealth Group  154,096   21,573,440 
      115,328,710 

 


 

STATEMENT OF INVESTMENTS (Unaudited) (continued)

Common Stocks - 96.9% (continued)  Shares   Value ($) 
Household & Personal Products - 1.6%       
Estee Lauder, Cl. A  198,378   17,568,356 
Insurance - 2.0%       
Arch Capital Group  279,072 a  22,119,247 
Materials - 4.2%       
Dow Chemical  310,589   16,097,828 
Praxair  121,865   14,724,948 
Vulcan Materials  140,609   15,991,462 
      46,814,238 
Media - 3.5%       
CBS, Cl. B  296,484   16,229,534 
Charter Communications, Cl. A  85,504 a  23,083,515 
      39,313,049 
Pharmaceuticals, Biotechnology & Life Sciences - 6.8%       
Celgene  204,570 a  21,383,702 
Merck & Co.  364,001   22,717,302 
Pfizer  971,616   32,908,634 
      77,009,638 
Retailing - 10.2%       
Amazon.com  57,583 a  48,214,822 
Home Depot  170,764   21,973,911 
Priceline Group  16,282 a  23,958,800 
Ulta Salon Cosmetics & Fragrance  87,001 a  20,704,498 
      114,852,031 
Semiconductors & Semiconductor Equipment - 4.0%       
Broadcom  129,252   22,298,555 
Texas Instruments  329,261   23,107,537 
      45,406,092 
Software & Services - 14.6%       
Alphabet, Cl. A  27,946 a  22,470,261 
Alphabet, Cl. C  37,463 a  29,119,615 
Facebook, Cl. A  330,790 a  42,430,433 
MasterCard, Cl. A  272,244   27,706,272 
Oracle  612,516   24,059,628 
salesforce.com  248,226 a  17,705,961 
      163,492,170 
Technology Hardware & Equipment - 2.3%       
Cisco Systems  802,509   25,455,585 
Transportation - 2.0%       
Union Pacific  233,223   22,746,239 

 


 

Common Stocks - 96.9% (continued)  Shares   Value ($)  
Utilities - 1.7%         
NextEra Energy  154,603   18,911,039  
Total Common Stocks (cost $871,464,817)      1,087,883,936  
Other Investment - 3.4%  Shares   Value ($)  
Registered Investment Company;         
Dreyfus Institutional Preferred Government Plus Money Market Fund         
     (cost $38,269,765)  38,269,765 b  38,269,765  
Total Investments (cost $909,734,582)  100.3 %  1,126,153,701  
Liabilities, Less Cash and Receivables  (.3 %)  (3,751,714 ) 
Net Assets  100.0 %  1,122,401,987  

 

a  Non-income producing security. 
b  Investment in affiliated money market mutual fund. 

 

Portfolio Summary (Unaudited)  Value (%) 
Software & Services  14.6 
Health Care Equipment & Services  10.3 
Retailing  10.2 
Energy  8.6 
Diversified Financials  7.2 
Capital Goods  6.9 
Pharmaceuticals, Biotechnology & Life Sciences  6.8 
Food, Beverage & Tobacco  5.2 
Materials  4.2 
Banks  4.0 
Semiconductors & Semiconductor Equipment  4.0 
Media  3.5 
Money Market Investment  3.4 
Technology Hardware & Equipment  2.3 
Insurance  2.0 
Transportation  2.0 
Food & Staples Retailing  1.8 
Utilities  1.7 
Household & Personal Products  1.6 
  100.3 

 

† Based on net assets. 
See notes to financial statements. 

 


 

STATEMENT OF INVESTMENTS
The Dreyfus Fund Incorporated
September 30, 2016 (Unaudited)

The following is a summary of the inputs used as of September 30, 2016 in valuing the fund’s investments:

    Level 2 - Other     
  Level 1 - Unadjusted  Significant  Level 3 -Significant   
  Quoted Prices  Observable Inputs Unobservable Inputs Total 
Assets ($)         
Investments in Securities:       
Equity Securities—         
Domestic Common         
Stocks  1,065,585,381  -  -  1,065,585,381 
Equity Securities—         
Foreign Common         
Stocks  22,298,555  -  -  22,298,555 
Mutual Funds  38,269,765  -  -  38,269,765 

 

  See Statement of Investments for additional detailed categorizations. 

 


 

NOTES

The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) is the exclusive reference of authoritative U.S. generally accepted accounting principles (“GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund’s financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund’s investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

Level 1—unadjusted quoted prices in active markets for identical investments.

Level 2—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

Level 3—significant unobservable inputs (including the fund’s own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund’s investments are as follows: Investments in securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. For open short positions, asked prices are used for valuation purposes. Bid price is used when no asked price is available. Registered investment companies that are not


 

NOTES

traded on an exchange are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. U.S. Treasury Bills are valued at the mean price between quoted bid prices and asked prices by an independent pricing service (the"Service") approved by the Board Members ("Board").These securities are generally categorized within Level 2 of the fair value hierarchy.

The Service’s procedures are reviewed by Dreyfus under the general supervision of the Board.

Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant American Depository Receipts and financial futures. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to reflect accurately fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board. Certain factors may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For restricted securities where observable inputs are limited, assumptions about market activity and risk are used and are generally categorized within Level 3 of the fair value hierarchy.

At September 30, 2016, accumulated net unrealized appreciation on investments was $216,419,119, consisting of $228,541,298 gross unrealized appreciation and $12,122,179 gross unrealized depreciation.

At September 30, 2016, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Statement of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.


 

Item 2.             Controls and Procedures.

(a)        The Registrant's principal executive and principal financial officers have concluded, based on their evaluation of the Registrant's disclosure controls and procedures as of a date within 90 days of the filing date of this report, that the Registrant's disclosure controls and procedures are reasonably designed to ensure that information required to be disclosed by the Registrant on Form N-Q is recorded, processed, summarized and reported within the required time periods and that information required to be disclosed by the Registrant in the reports that it files or submits on Form N-Q is accumulated and communicated to the Registrant's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

(b)        There were no changes to the Registrant's internal control over financial reporting that occurred during the Registrant's most recently ended fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Registrant's internal control over financial reporting. 

Item 3.             Exhibits.

(a)        Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) under the Investment Company Act of 1940.


 

FORM N-Q

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

The Dreyfus Fund Incorporated

By:       /s/ Bradley J. Skapyak

            Bradley J. Skapyak

            President

 

Date:    November 16, 2016

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 

By:       /s/ Bradley J. Skapyak

            Bradley J. Skapyak

            President

 

Date:    November 16, 2016

 

By:       /s/ James Windels

            James Windels

            Treasurer

 

Date:    November 16, 2016

 

EXHIBIT INDEX

(a)        Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) under the Investment Company Act of 1940.  (EX-99.CERT)

EX-99.CERT 2 cert302026.htm CERTIFICATION cert302026.htm - Generated by SEC Publisher for SEC Filing

SECTION 302 CERTIFICATION

I, Bradley J. Skapyak, certify that:

1.  I have reviewed this report on Form N-Q of The Dreyfus Fund Incorporated;

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  Based on my knowledge, the schedule of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4.  The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;

5.  The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

                                                                        By:       /s/ Bradley J. Skapyak

                                                                                    Bradley J. Skapyak

                                                                                    President

                                                                        Date:    November 16, 2016

1


 

SECTION 302 CERTIFICATION

I, James Windels, certify that:

1.  I have reviewed this report on Form N-Q of The Dreyfus Fund Incorporated;

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  Based on my knowledge, the schedule of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4.  The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;

5.  The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

                                                                  By:       /s/ James Windels

                                                                                    James Windels

                                                                                    Treasurer

                                                                        Date:    November 16, 2016

2